Regulation (EU) 2019/6
Regulation (EU) 2019/6 of the European Parliament and of the Council of 11 December 2018 on veterinary medicinal products and repealing Directive 2001/82/EC (Text with EEA relevance)
Section 2 Dossier requirements
Section 4 Labelling and package leaflet
- 10Labelling of the immediate packaging of veterinary medicinal products
- 11Labelling of the outer packaging of veterinary medicinal products
- 12Labelling of small immediate packaging units of veterinary medicinal products
- 13Additional information on the immediate packaging or outer packaging of veterinary medicinal products
- 14Package leaflet of veterinary medicinal products
- 15General requirement regarding product information
- 16Package leaflet of registered homeopathic veterinary medicinal products
- 17Implementing powers with respect to this Section
Section 6 Marketing authorisations for limited market and in exceptional circumstances
- 23Applications for limited markets
- 24Validity of a marketing authorisation for a limited market and procedure for its re-examination
- 25Applications in exceptional circumstances
- 26Terms of the marketing authorisation in exceptional circumstances
- 27Validity of a marketing authorisation in exceptional circumstances and procedure for its re-examination
Section 7 Examination of applications and basis for granting marketing authorisations
- 28Examination of applications
- 29Requests to laboratories in the course of the examination of applications
- 30Information on manufacturers in third countries
- 31Additional information from the applicant
- 32Withdrawal of applications
- 33Outcome of the assessment
- 34Classification of veterinary medicinal products
- 35Summary of the product characteristics
- 36Decisions granting marketing authorisations
- 37Decisions refusing marketing authorisations
Section 8 Protection of technical documentation
Section 1 Union product database
Section 3 Changes to the terms of the marketing authorisations
- 60Variations
- 61Variations that do not require assessment
- 62Application for variations requiring assessment
- 63Consequential changes to product information
- 64Groups of variations
- 65Work-sharing procedure
- 66Procedure for variations requiring assessment
- 67Measures to close the procedure for variations requiring assessment
- 68Implementation of variations requiring assessment
- 69Scope of the harmonisation of summaries of product characteristics of a veterinary medicinal product
- 70Procedure for harmonisation of summaries of product characteristics for the reference veterinary medicinal
- 71Procedure for harmonisation of summaries of product characteristics for generic and hybrid veterinary medic
- 72Environmental safety documentation and environmental risk assessment of certain veterinary medicinal produc
- 73Union pharmacovigilance system
- 74Union pharmacovigilance database
- 75Access to the pharmacovigilance database
- 76Reporting and recording of suspected adverse events
- 77Pharmacovigilance responsibilities of the marketing authorisation holder
- 78Qualified person responsible for pharmacovigilance
- 79Pharmacovigilance responsibilities of the competent authorities and the Agency
- 80Delegation of tasks by competent authority
- 81Signal management process
Section 6 Union interest referral
- 88Manufacturing authorisations
- 89Application for manufacturing authorisation
- 90Procedure for granting of manufacturing authorisations
- 91Database on manufacturing and wholesale distribution
- 92Changes to manufacturing authorisations on request
- 93Obligations of the holder of a manufacturing authorisation
- 94Certificates of good manufacturing practice
- 95Importers, manufacturers and distributors of active substances established in the Union
- 96Record keeping
- 97Qualified person responsible for manufacturing and batch release
- 98Certificates of veterinary medicinal products
Section 1 Wholesale distribution
- 106Use of medicinal products
- 107Use of antimicrobial medicinal products
- 108Record-keeping by owners and keepers of food-producing animals
- 109Record-keeping obligations for equine animals
- 110Use of immunological veterinary medicinal products
- 111Use of veterinary medicinal products by veterinarians providing services in other Member States
- 112Use of medicinal products outside the terms of the marketing authorisation in non-food-producing animal sp
- 113Use of medicinal products outside the terms of the marketing authorisation in food-producing terrestrial a
- 114Use of medicinal products for food-producing aquatic species
- 115Withdrawal period for medicinal products used outside the terms of the marketing authorisation in food-pro
- 116Health situation
- 117Collection and disposal of waste of veterinary medicinal products
- 118Animals or products of animal origin imported into the Union
- 129Temporary safety restrictions
- 130Suspending, revoking, or varying the terms, of marketing authorisations
- 131Suspending or revoking a wholesale distribution authorisation
- 132Removal of importers, manufacturers and distributors of active substance from the manufacturing and wholes
- 133Suspending or revoking manufacturing authorisations
- 134Prohibiting the supply of veterinary medicinal products
- 135Penalties imposed by Member States
- 136Financial penalties imposed by the Commission on holders of marketing authorisation for centrally authoris
- 137Competent authorities
- 138Scientific opinion for international organisations for animal health
- 139Committee for Veterinary Medicinal Products
- 140Members of the Committee
- 141Tasks of the Committee
- 142Coordination group for mutual recognition and decentralised procedures for veterinary medicinal products
- 143Members of the coordination group
- 144Tasks of the coordination group
- 149Repeal
- 150Relation with other Union acts
- 151Prior applications
- 152Existing veterinary medicinal products, marketing authorisations and registrations
- 153Transitional provisions regarding delegated and implementing acts
- 154Establishment of the pharmacovigilance database and of the manufacturing and wholesale distribution databa
- 155Initial input to the product database by competent authorities
- 156Review of rules for environmental risk assessment
- 157Commission report on traditional herbal products used to treat animals
- 158Review of measures regarding animals of the equine species
- 159Transitional provisions regarding certain certificates of good manufacturing practice
- 160Entry into force and application
Source: EU legislation in force, consolidated versions and treaties (Cellar, Publications Office). Official publication. Reuse: Reuse authorised (Commission Decision 2011/833/EU).